FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

✍ Scribed by Koolen, Bas B.; Pengel, Kenneth E.; Wesseling, Jelle; Vogel, Wouter V.; Vrancken Peeters, Marie-Jeanne T.F.D.; Vincent, Andrew D.; Gilhuijs, Kenneth G.A.; Rodenhuis, Sjoerd; Rutgers, Emiel J.Th.; Valdés Olmos, Renato A.

• Book ID: 120445541
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 535 KB
• Volume: 22
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/j.breast.2012.12.020